Syngene International Limited

Syngene International Limited

Syngene International Limited has informed the Exchange about the resignation of a Director/KMP/SMP.

Syngene International Limited

Syngene International Limited has informed the Exchange regarding Resignation of Mr Kush Parmar as Independent Director of the company w.e.f. July 29, 2026.

Syngene International Limited

Syngene International Limited has announced its Q1 FY27 results, with revenue from operations at Rs. 736 Cr and operating EBITDA at Rs. 91 Cr, showing a decline of 16% and 56% respectively compared to Q1 FY26.

Syngene International Limited

Syngene International Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, with a profit before tax of Rs. 192 million and a profit for the period of Rs. 90 million. The company's revenue from operations was Rs. 7,360 million, and its expenses were Rs. 7,670 million. The results also include a statement of unaudited consolidated financial results.

Syngene International Limited

Syngene International Limited has informed the Exchange about a conference call with analysts and investors to discuss Q1 FY 2026-27 financial results on July 30, 2026.

Syngene International Limited

Syngene International Limited has informed the Exchange about change in Management due to General Counsel Surender Sharma leaving the Company by mutual consent to pursue other career opportunities.

Syngene International Limited

Syngene International Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities during the quarter ended June 30, 2026.

Syngene International Limited

Syngene International Limited has informed the Exchange about the resignation of its Statutory Auditor.

Syngene International Limited

Syngene International Limited has informed the Exchange regarding Resignation of M/s B S R & Co. LLP, Statutory Auditor of material subsidiary Syngene Scientific Solutions Limited, effective July 07, 2026.

Syngene International Limited

Syngene International Limited has informed the Exchange about the receipt of an order dated May 14, 2026, giving effect to the order passed by the National Faceless Appeal Centre (NFAC) for Assessment Year (AY) 2014-15. The order partly allowed the appeal and granted a refund of Rs. 8,62,14,600/- (including interest). The Company believes there may not be material impact on its financials, operations, or activities.

Syngene International Limited

Syngene International Limited has informed the Exchange regarding the resignation of Mr. Peter Bains as Managing Director & Chief Executive Officer, effective June 30, 2026.

Syngene International Limited

Syngene International Limited has informed the Exchange about the publication of a newspaper advertisement regarding the Notice of the 33rd Annual General Meeting and Annual Report for FY 2025-26.

Syngene International Limited

Syngene International Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on July 29, 2026. The meeting will consider and approve the appointment of Professor Catherine Rosenberg as Director, adoption of audited financial statements, and declaration of a final dividend of `1.25 per equity share for the Financial Year ended March 31, 2026. The meeting will also consider the appointment of S. R. Batliboi & Associates LLP as the Statutory Auditors of the Company.

Syngene International Limited

Syngene International Limited has announced the appointment of Siddharth Mittal as the Managing Director and Chief Executive Officer of the company, effective July 1, 2026. Mittal succeeds Peter Bains, who completed his tenure as Managing Director & CEO on June 30, 2026. Mittal brings close to three decades of business leadership experience, having held various positions at Biocon Limited, including Chief Financial Officer and Managing Director & CEO.

Syngene International Limited

Syngene International Limited has informed the Exchange about the intimation of the 33rd Annual General Meeting, record date, and final dividend information.

Syngene International Limited

Syngene International Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Syngene International Limited

Syngene International Limited has informed the Exchange about Email communication sent to Shareholders - TDS on Final Dividend. The company has recommended a final dividend at the rate of 12.50% for the Financial Year ended March 31, 2026, subject to the approval of shareholders at the ensuing 33rd Annual General Meeting scheduled to be held on July 29, 2026.

Syngene International Limited

Syngene International Limited has submitted the voting results and scrutinizer's report for its recent Postal Ballot. Shareholders approved, via a Special Resolution, the change in the role of Ms. Kiran Mazumdar-Shaw from Non-Executive Chairperson to Executive Chairperson. This decision signifies a key shift in the company's leadership structure, bringing its founder into a more active executive capacity. Investors should note this governance change and its potential implications for the company's strategic direction and operational oversight.